Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Details

Connection

Melanie Everitt to Adult

This is a "connection" page, showing publications Melanie Everitt has written about Adult.

 
Connection Strength
  
 
 
0.233
  
  1. Kaza AK, Kaza E, Bullock E, Reyna S, Yetman A, Everitt MD. Pulmonary vascular remodelling after heart transplantation in patients with cavopulmonary connection. Eur J Cardiothorac Surg. 2015 Mar; 47(3):505-10; discussion 510.
    View in: PubMed
    Score: 0.026
  2. Boucek D, Yetman AT, Yeung E, Miyamoto SD, Stehlik J, Kfoury AG, Kaza AK, Weng C, Everitt MD. Survival based on patient selection for heart transplant in adults with congenital heart disease: a multi-institutional study. Int J Cardiol. 2014; 172(1):e89-90.
    View in: PubMed
    Score: 0.026
  3. Yetman AT, Roosevelt GE, Veit N, Everitt MD. Distal aortic and peripheral arterial aneurysms in patients with Marfan syndrome. J Am Coll Cardiol. 2011 Dec 06; 58(24):2544-5.
    View in: PubMed
    Score: 0.022
  4. Yetman AT, Everitt MD. The role of iron deficiency in protein-losing enteropathy following the Fontan procedure. Congenit Heart Dis. 2011 Jul-Aug; 6(4):370-3.
    View in: PubMed
    Score: 0.021
  5. Everitt MD, Donaldson AE, Stehlik J, Kaza AK, Budge D, Alharethi R, Bullock EA, Kfoury AG, Yetman AT. Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). J Heart Lung Transplant. 2011 Apr; 30(4):395-401.
    View in: PubMed
    Score: 0.021
  6. Kirmani S, Woodard PK, Shi L, Hamza TH, Canter CE, Colan SD, Pahl E, Towbin JA, Webber SA, Rossano JW, Everitt MD, Molina KM, Kantor PF, Jefferies JL, Feingold B, Addonizio LJ, Ware SM, Chung WK, Ballweg JA, Lee TM, Bansal N, Razoky H, Czachor J, Lunze FI, Marcus E, Commean P, Wilkinson JD, Lipshultz SE. Cardiac imaging and biomarkers for assessing myocardial fibrosis in children with hypertrophic cardiomyopathy. Am Heart J. 2023 10; 264:153-162.
    View in: PubMed
    Score: 0.012
  7. Amdani S, Henderson H, Everitt MD, Beasley G, Shih R, Exil V, Alejos J, Wallis G, Azeka E, Nandi D, Profita E, Spinner J, Magnetta D, Martinez H, Fenton M, Conway J, Urschel S. Clinical approach to antibody-mediated rejection from the pediatric heart transplant society. Pediatr Transplant. 2022 12; 26(8):e14398.
    View in: PubMed
    Score: 0.012
  8. Chen TT, Greene MM, Everitt MD, Simpson KE. Basiliximab as maintenance immunosuppression in heart transplant recipients: A single pediatric center experience. Pediatr Transplant. 2023 03; 27(2):e14438.
    View in: PubMed
    Score: 0.012
  9. Heble A, Everitt MD, Gralla J, Miyamoto SD, Lahart M, Eshelman J. Safety of mTOR inhibitor continuation in pediatric heart transplant recipients undergoing surgical procedures. Pediatr Transplant. 2018 02; 22(1).
    View in: PubMed
    Score: 0.008
  10. Bogarapu S, Puchalski MD, Everitt MD, Williams RV, Weng HY, Menon SC. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy. Pediatr Cardiol. 2016 Apr; 37(4):663-73.
    View in: PubMed
    Score: 0.007
  11. Lindsay I, Johnson J, Everitt MD, Hoffman J, Yetman AT. Impact of liver disease after the fontan operation. Am J Cardiol. 2015 Jan 15; 115(2):249-52.
    View in: PubMed
    Score: 0.007
  12. Johnson JT, Lindsay I, Day RW, Van Dorn CS, Hoffman J, Everitt MD, Yetman AT. Living at altitude adversely affects survival among patients with a Fontan procedure. J Am Coll Cardiol. 2013 Mar 26; 61(12):1283-9.
    View in: PubMed
    Score: 0.006
  13. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation. 2013 Jan 29; 127(4):452-62.
    View in: PubMed
    Score: 0.006
  14. Revelo MP, Miller DV, Stehlik J, Brunisholz K, Drakos S, Gilbert EM, Everitt M, Budge D, Alharethi R, Snow G, Hammond EH, Kfoury AG. Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection. Cardiovasc Pathol. 2012 Nov-Dec; 21(6):445-54.
    View in: PubMed
    Score: 0.006
  15. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond ME. A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2012 Jan; 31(1):46-51.
    View in: PubMed
    Score: 0.006
  16. Nixon JL, Kfoury AG, Brunisholz K, Horne BD, Myrick C, Miller DV, Budge D, Bader F, Everitt M, Saidi A, Stehlik J, Schmidt TC, Alharethi R. Impact of high-dose inotropic donor support on early myocardial necrosis and outcomes in cardiac transplantation. Clin Transplant. 2012 Mar-Apr; 26(2):322-7.
    View in: PubMed
    Score: 0.005
  17. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J. Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant. 2011 Dec; 11(12):2755-61.
    View in: PubMed
    Score: 0.005
  18. Revelo MP, Stehlik J, Miller D, Snow GL, Everitt MD, Budge D, Bader FM, Alharethi RA, Gilbert EM, Reid BB, Selzman CH, Hammond ME, Kfoury AG. Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death? J Heart Lung Transplant. 2011 Feb; 30(2):144-50.
    View in: PubMed
    Score: 0.005
  19. Kotter JR, Drakos SG, Horne BD, Hammond EH, Stehlik J, Bull DA, Reid BB, Gilbert EM, Everitt M, Alharethi R, Budge D, Verma DR, Li DY, Li Y, Kfoury AG. Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection. Transplant Proc. 2010 Sep; 42(7):2687-92.
    View in: PubMed
    Score: 0.005
  20. Nativi JN, Kfoury AG, Myrick C, Peters M, Renlund D, Gilbert EM, Bader F, Singhal AK, Everitt M, Fisher P, Bull DA, Selzman C, Stehlik J. Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. J Heart Lung Transplant. 2010 Mar; 29(3):235-9.
    View in: PubMed
    Score: 0.005
  21. Kfoury AG, Hammond ME, Snow GL, Drakos SG, Stehlik J, Fisher PW, Reid BB, Everitt MD, Bader FM, Renlund DG. Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant. 2009 Aug; 28(8):781-4.
    View in: PubMed
    Score: 0.005
  22. Kfoury AG, Renlund DG, Snow GL, Stehlik J, Folsom JW, Fisher PW, Reid BB, Clayson SE, Gilbert EM, Everitt MD, Bader FM, Singhal AK, Hammond ME. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. J Heart Lung Transplant. 2009 Jan; 28(1):51-7.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)